Lonza Group AG
LONN
Pozycja w akcjach
#449
Lonza Group AG, together with its subsidiaries, operates as a contract... Lonza Group AG, together with its subsidiaries, operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Integrated Biologics; Advanced Synthesis; and Specialized Modalities segments. The Integrated Biologics segment offers CDMO biologics services from clinical development, drug substance, and drug product manufacturing; and operates mammalian and drug product platforms. Its Advanced Synthesis segment manufactures antibody-drug conjugates (ADCs) and other bioconjugates, small molecules, and highly potent active pharmaceutical ingredients; and operates small molecules and bioconjugates platforms. The Specialized Modalities segment operates various technologies, such as spanning cell & gene, microbial, bioscience, and mRNA. Lonza Group AG was incorporated in 1897 and is headquartered in Basel, Switzerland.
Cena akcji
$763.31
Kapitalizacja rynkowa
$53.31B
Zmiana (1 dzień)
0.87%
Zmiana (1 rok)
8.49%
Kraj
CH
Handel Lonza Group AG (LONN)
Kategoria
Healthcare
Liczba akcji w obrocie dla Lonza Group AG (LONN)
Liczba akcji w obrocie na dzień October 2026: 0
Zgodnie z najnowszymi raportami finansowymi i ceną akcji Lonza Group AG, aktualna liczba akcji w obrocie to 0. Na koniec October 2026 firma posiadała 0 akcji w obrocie. Liczba akcji w obrocie jest zwykle kształtowana przez podziały akcji i skupy akcji.
Historia liczby akcji w obrocie dla Lonza Group AG (LONN) od 2004 do 2026
Akcje w obrocie na koniec każdego roku
| Rok | Akcje w obrocie | Zmień |
|---|---|---|
| 2025 | 70.02M | -1.68% |
| 2024 | 71.22M | -3.30% |
| 2023 | 73.65M | -0.78% |
| 2022 | 74.23M | -0.04% |
| 2021 | 74.26M | -0.20% |
| 2020 | 74.40M | 0.40% |
| 2019 | 74.11M | -0.40% |
| 2018 | 74.41M | 9.62% |
| 2017 | 67.88M | 28.40% |
| 2016 | 52.87M | 0.39% |
| 2015 | 52.66M | 0.91% |
| 2014 | 52.19M | 0.18% |
| 2013 | 52.10M | -6.80% |
| 2012 | 55.90M | 0.28% |
| 2011 | 55.74M | -1.48% |
| 2010 | 56.58M | 3.22% |
| 2009 | 54.81M | -3.69% |
| 2008 | 56.91M | -0.10% |
| 2007 | 56.97M | -3.42% |
| 2006 | 58.99M | 15.34% |
| 2005 | 51.15M | -0.01% |
| 2004 | 51.15M | 0.00% |
Akcje w obrocie dla podobnych firm lub konkurentów
| Firma | Akcje w obrocie | Różnica | Kraj |
|---|---|---|---|
| 253.90M | - |
US
|
|
| 396.00M | - |
US
|
|
| 478.91M | - |
AU
|
|
| 62.19M | - |
NL
|
|
| 0.00 | - |
BE
|
